Suppr超能文献

紧密连接蛋白16通道基因受到1,25-二羟维生素D的转录抑制。

The claudin-16 channel gene is transcriptionally inhibited by 1,25-dihydroxyvitamin D.

作者信息

Kladnitsky Orly, Rozenfeld Julia, Azulay-Debby Hilla, Efrati Edna, Zelikovic Israel

机构信息

Laboratory of Developmental Nephrology, Department of Physiology and Biophysics, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

出版信息

Exp Physiol. 2015 Jan;100(1):79-94. doi: 10.1113/expphysiol.2014.083394. Epub 2014 Dec 2.

Abstract

What is the central question of this study? In the kidney, the bulk of the filtered Mg(2+) is reabsorbed in the thick ascending limb by paracellular conductance, mediated by the tight junction protein, claudin-16, which is encoded by the gene CLDN16. The role of 1,25-dihydroxyvitamin D [1,25(OH)2 VitD] in renal Mg(2+) handling is unclear. We aimed to explore the molecular mechanisms underlying the effect of 1,25(OH)2 VitD on claudin-16-mediated Mg(2+) transport. What is the main finding and its importance? Paracellular, claudin-16-mediated Mg(2+) transport is transcriptionally repressed by 1,25(OH)2 VitD, probably via a Ca(2+)-sensing receptor-dependent mechanism. This renal effect of 1,25(OH)2 VitD may serve as an adaptive mechanism to the 1,25(OH)2 VitD-induced enteric hyperabsorption of dietary Mg(2+). Magnesium is reabsorbed in the thick ascending limb by paracellular conductance, mediated by the CLDN16-encoded tight junction protein, claudin-16. However, the role of 1,25-dihydroxyvitamin D [1,25(OH)2 VitD] in renal Mg(2+) handling is unclear. We have shown that Mg(2+) depletion increases and 1,25(OH)2 VitD inhibits CLDN16 transcription. We have now explored further the molecular mechanisms underlying the effect of 1,25(OH)2 VitD on claudin-16-mediated Mg(2+) transport. Adult mice received parenteral 1,25(OH)2 VitD or 1,25(OH)2 VitD combined with either high-Mg(2+) or low-Mg(2+) diets. Administration of 1,25(OH)2 VitD enhanced urinary excretion of Mg(2+) and Ca(2+). The 1,25(OH)2 VitD also increased renal Ca(2+)-sensing receptor (CaSR) mRNA and decreased renal claudin-16 and claudin-19 mRNA and claudin-16 protein, but did not affect renal claudin-2 mRNA. The 1,25(OH)2 VitD reversed the expected increase in claudin-16 mRNA in Mg(2+)-depleted animals. Comparably treated HEK 293 cells showed similar changes in claudin-16 mRNA, but 1,25(OH)2 VitD did not alter mRNA of the TRPM6 Mg(2+) channel. A luciferase reporter vector containing 2.5 kb of 5'-flanking DNA sequence from human CLDN16 (hCLDN16) was transfected into HEK 293 and OK cells. The hCLDN16 promoter activity was modestly decreased by 1,25(OH)2 VitD, but markedly inhibited in HEK 293 cells coexpressing CaSR. Coexpression in OK cells of dominant-negative CaSR completely abolished inhibition of hCLDN16 promoter activity by 1,25(OH)2 VitD. The 1,25(OH)2 VitD-induced decrease in hCLDN16 promoter activity was attenuated in Mg(2+)-depleted HEK 293 cells. In conclusion, 1,25(OH)2 VitD transcriptionally inhibits claudin-16 expression by a mechanism sensitive to CaSR and Mg(2+). This renal effect of 1,25(OH)2 VitD may serve as an adaptive response to the 1,25(OH)2 VitD-induced increase in intestinal Mg(2+) absorption.

摘要

本研究的核心问题是什么?在肾脏中,大部分滤过的镁离子(Mg²⁺)通过紧密连接蛋白claudin - 16介导的细胞旁电导在厚壁升支重吸收,claudin - 16由CLDN16基因编码。1,25 - 二羟基维生素D [1,25(OH)₂VitD] 在肾脏镁离子处理中的作用尚不清楚。我们旨在探究1,25(OH)₂VitD对claudin - 16介导的镁离子转运作用的分子机制。主要发现及其重要性是什么?细胞旁claudin - 16介导的镁离子转运受到1,25(OH)₂VitD的转录抑制,可能是通过一种依赖于钙敏感受体(CaSR)的机制。1,25(OH)₂VitD的这种肾脏效应可能是对1,25(OH)₂VitD诱导的肠道对膳食镁离子过度吸收的一种适应性机制。镁离子通过由CLDN16编码的紧密连接蛋白claudin - 16介导的细胞旁电导在厚壁升支重吸收。然而,1,25 - 二羟基维生素D [1,25(OH)₂VitD] 在肾脏镁离子处理中的作用尚不清楚。我们已经表明镁离子缺乏会增加而1,25(OH)₂VitD会抑制CLDN16转录。我们现在进一步探究1,25(OH)₂VitD对claudin - 16介导的镁离子转运作用的分子机制。成年小鼠接受肠外给予的1,25(OH)₂VitD或1,25(OH)₂VitD与高镁或低镁饮食联合处理。给予1,25(OH)₂VitD会增加镁离子和钙离子的尿排泄。1,25(OH)₂VitD还会增加肾脏钙敏感受体(CaSR)mRNA,并降低肾脏claudin - 16和claudin - 19 mRNA以及claudin - 16蛋白,但不影响肾脏claudin - 2 mRNA。1,25(OH)₂VitD逆转了镁离子缺乏动物中claudin - 16 mRNA预期的增加。经类似处理的人胚肾293(HEK 293)细胞在claudin - 16 mRNA上显示出类似变化,但1,25(OH)₂VitD未改变瞬时受体电位阳离子通道亚家族M成员6(TRPM6)镁离子通道的mRNA。将含有来自人CLDN16(hCLDN16)的2.5 kb 5'侧翼DNA序列的荧光素酶报告载体转染到HEK 293细胞和OK细胞中。1,25(OH)₂VitD使hCLDN16启动子活性适度降低,但在共表达CaSR的HEK 293细胞中受到显著抑制。在OK细胞中共表达显性负性CaSR完全消除了1,25(OH)₂VitD对hCLDN16启动子活性的抑制。在镁离子缺乏的HEK 293细胞中,1,25(OH)₂VitD诱导的hCLDN16启动子活性降低减弱。总之,1,25(OH)₂VitD通过一种对CaSR和镁离子敏感的机制转录抑制claudin - 16表达。1,25(OH)₂VitD的这种肾脏效应可能是对1,25(OH)₂VitD诱导的肠道镁离子吸收增加的一种适应性反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验